Skip to main content

Table 5 Logistic regression analysis for risk factors of AF in the study participants

From: Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation

Parameters

No. subjects

P

Non-adjusted

OR(95 % CI)

P

Adjusted

OR(95 % CI)

Age

     

(< 65y)

396

 

(Ref.)

 

(Ref.)

(≥ 65y)

971

< 0.001

2.937(2.298–3.754)

< 0.001

2.848(1.894–4.283)

DBP

     

(< 90mm Hg)

952

 

(Ref.)

 

(Ref.)

(≥ 90mm Hg)

415

< 0.001

1.471(1.166–1.857)

0.018

1.556(1.080–2.240)

APOE-ε4 carrier

     

no

961

 

(Ref.)

 

(Ref.)

yes

406

0.053

1.258(0.997–1.588)

0.683

1.079(0.748–1.558)

TC

     

(< 5.2mmol/L)

1141

 

(Ref.)

 

(Ref.)

(≥ 5.2mmol/L)

226

< 0.001

4.305(3.066–6.045)

< 0.001

3.879(2.003–7.513)

TG

     

(< 1.7mmol/L)

1104

 

(Ref.)

 

(Ref.)

(≥ 1.7mmol/L)

263

< 0.001

1.823(1.382–2.406)

0.028

1.596(1.053–2.419)

LDL-C

     

(< 3.4mmol/L)

1240

 

(Ref.)

 

(Ref.)

(≥ 3.4mmol/L)

127

< 0.001

6.522(3.913–10.872)

0.596

1.308(0.485–3.527)

Apo-B

     

(< 1.1 g/L)

1242

 

(Ref.)

 

(Ref.)

(≥ 1.1 g/L)

125

< 0.001

3.983(2.550–6.222)

0.459

1.380(0.589–3.233)

  1. OR in adjusted model was adjusted for LAD, LVDd, LVSd, LVEF, ALT, AST, UN, Scr, UA, CAD, HF, use of ACEIs, BBs, MRAs, digoxin and diuretics
  2. OR: odds ratio; CI: confidence interval. Other abbreviations see in Tables 1 and 2